Washington Biotechnology & Biomedical Association Release: Invest Northwest(C) Life Science CEO & Investor Forum Announces Final Slate Of Conference Speakers

SEATTLE, March 3 /PRNewswire/ -- The Washington Biotechnology & Biomedical Association (WBBA) announced today the complete roster of distinguished panelists and speakers for the 5th Annual Invest Northwest Life Science CEO & Investor Forum (Invest Northwest) scheduled for March 21-22, 2006 in Seattle. Panelists and speakers, in order of appearance, will be:

Tuesday - March 21 Welcome speaker: Global Partnerships Cheryl North, Director, Pharmaceutical & Life Science Industry, Microsoft Healthcare & Life Sciences Mid-Morning Concurrent Panels: Medical Device Business Development Chair: Trevor Moody, Frazier Healthcare Ventures. Panelists: Tony Chou, Abbott Vascular Devices; Samie Hamade, Guidant; Roger Guidi, J&J Development; and Thomas Dugan, SonoSite. Biopharma Business Development Chair: Patrick Heron, Frazier Healthcare Ventures. Panelists: Andrew Gengos, Amgen; Jim Schaeffer, Merck; Fran Heller, Novartis and Robert Smith, Wyeth. Luncheon Panel: Creative Frontiers between Industry and Academia Chair: Jack Faris, WBBA. Panelists: Carl Weissman, Accelerator Corp; Adrian Roberts, Battelle-OR; Angus Livingstone, University of British Columbia and Lura Powell, Washington State Life Sciences Discovery Fund. Mid-afternoon Panel: State of the IPO Market Chair: Bruce L.A. Carter, ZymoGenetics. Panelists: Alexander Arrow, Lazard Capital Markets; Mark Monane, Needham & Company; Greg Wade, Pacific Growth Equities and Eric Schmidt, SG Cowen. Keynote Speaker: Modernization of the FDA and Plan for the Future Scott Gottlieb, U.S. FDA Deputy Commissioner Wednesday, March 22 Welcome: Making Markets Work for Global Health Christopher Earl, President, CEO and Director of Bio Ventures for Global Health Mid-morning concurrent panels: Biopharma VC Panel Chair: Karen Bernstein, BioCentury. Panelists: Robert Nelsen, ARCH Venture Partners; Brenda Irwin, BDC Venture Capital; Giovanni Ferrara, Burrill & Co; Rodney Ferguson, JPMorgan Partners and Andy Schwab, 5AM Ventures. Medical Device VC Panel Chair: Rebecca Robertson, Versant Ventures. Panelists: Michael Carusi, ATV Ventures; Stephen Campe, Investor Growth; Wilf Jaeger, Three Arch Ventures. Lunch: Life Cycle Management for Emerging Pharmaceutical Companies - How to Maximize Value Using Financing, Partnering and M&A as Your Company Evolves Chair: George Milstein, Pacific Growth Equities. Panelists: Todd Patrick, ID Biomedical; George Montgomery, Montgomery & Co; Cathy Friedman, Morgan Stanley and Mark Secrest, SG Cowen. Extended program at 1:45: Washington State Life Sciences Discovery Fund Discussion with Life Sciences Discovery Fund trustees

In addition to the seven panel discussions, the welcoming speakers and the keynote speaker, Invest Northwest will feature company presentations from 57 Pacific Northwest life science firms.

Now in its fifth year, Invest Northwest is a forum for senior executives from Northwest public and private life science companies to tell their stories to institutional investors, analysts, investment bankers, fund managers, venture capitalists, angel investors and prospective corporate partners. Invest Northwest is produced by the Washington Biotechnology & Biomedical Association in collaboration with BC Biotech, BC Medtech, BioAlberta, BioIdaho, Montana BioScience Alliance and the Oregon Bioscience Association.

Members of the professional investment community and bioscience leaders are invited to register online at www.washbio.org or call WBBA for more information at 206-624-1967.

About the Washington Biotechnology & Biomedical Association

Based in Seattle, the Washington Biotechnology & Biomedical Association (WBBA) is a not-for-profit association of Washington state-based biotechnology and medical device companies, research institutions and related organizations. For more information about WBBA, visit www.wabio.com.

For further information, contact: Washington Biotechnology & Biomedical Association Pam Love, 206-624-1967 pamlove@washbio.org

Washington Biotechnology & Biomedical Association

CONTACT: Pam Love of Washington Biotechnology & Biomedical Association,+1-206-624-1967, or pamlove@washbio.org

Back to news